Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction
Notoginsenoside R1 (NGR1) is the main monomeric component extracted from the dried roots and rhizomes of Panax notoginseng, and exerts pharmacological action against myocardial infarction (MI). Owing to the differences in compound distribution, absorption, and metabolism in vivo, exploring a more ef...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-08-01
|
| Series: | Redox Biology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231722001562 |
| _version_ | 1828773983874449408 |
|---|---|
| author | Han Li Jing Zhu Yan-wu Xu Fang-fang Mou Xiao-li Shan Qiang-li Wang Bao-nian Liu Ke Ning Jia-jia Liu Ya-chao Wang Jin-xia Mi Xiaohui Wei Shui-jin Shao Guo-hong Cui Rong Lu Hai-dong Guo |
| author_facet | Han Li Jing Zhu Yan-wu Xu Fang-fang Mou Xiao-li Shan Qiang-li Wang Bao-nian Liu Ke Ning Jia-jia Liu Ya-chao Wang Jin-xia Mi Xiaohui Wei Shui-jin Shao Guo-hong Cui Rong Lu Hai-dong Guo |
| author_sort | Han Li |
| collection | DOAJ |
| description | Notoginsenoside R1 (NGR1) is the main monomeric component extracted from the dried roots and rhizomes of Panax notoginseng, and exerts pharmacological action against myocardial infarction (MI). Owing to the differences in compound distribution, absorption, and metabolism in vivo, exploring a more effective drug delivery system with a high therapeutic targeting effect is crucial. In the early stages of MI, CD11b-expressing monocytes and neutrophils accumulate at infarct sites. Thus, we designed a mesoporous silica nanoparticle-conjugated CD11b antibody with loaded NGR1 (MSN-NGR1-CD11b antibody), which allowed NGR1 precise targeted delivery to the heart in a noninvasively manner. By increasing targeting to the injured myocardium, intravenous injection of MSN-NGR1-CD11b antibody nanoparticle in MI mice improved cardiac function and angiogenesis, reduced cell apoptosis, and regulate macrophage phenotype and inflammatory factors and chemokines. In order to further explore the mechanism of NGR1 protecting myocardium, cell oxidative stress model and oxygen-glucose deprivation (OGD) model were established. NGR1 protected H9C2 cells and primary cardiomyocytes against oxidative injury induced by H2O2 and OGD treatment. Further network pharmacology and molecular docking analyses suggested that the AKT, MAPK and Hippo signaling pathways were involved in the regulation of NGR1 in myocardial protection. Indeed, NGR1 could elevate the levels of p-Akt and p-ERK, and promote the nuclear translocation of YAP. Furthermore, LY294002 (AKT inhibitor), U0126 (ERK1/2 inhibitor) and Verteporfin (YAP inhibitor) administration in H9C2 cells indicated the involvement of AKT, MAPK and Hippo signaling pathways in NGR1 effects. Meanwhile, MSN-NGR1-CD11b antibody nanoparticles enhanced the activation of AKT and MAPK signaling pathways and the nuclear translocation of YAP at the infarcted site. Our research demonstrated that MSN-NGR1-CD11b antibody nanoparticle injection after MI enhanced the targeting of NGR1 to the infarcted myocardium and improved cardiac function. More importantly, our pioneering research provides a new strategy for targeting drug delivery systems to the ischemic niche. |
| first_indexed | 2024-12-11T15:13:08Z |
| format | Article |
| id | doaj.art-58af7e72154c4650b9e321877b63dabb |
| institution | Directory Open Access Journal |
| issn | 2213-2317 |
| language | English |
| last_indexed | 2024-12-11T15:13:08Z |
| publishDate | 2022-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Redox Biology |
| spelling | doaj.art-58af7e72154c4650b9e321877b63dabb2022-12-22T01:00:41ZengElsevierRedox Biology2213-23172022-08-0154102384Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarctionHan Li0Jing Zhu1Yan-wu Xu2Fang-fang Mou3Xiao-li Shan4Qiang-li Wang5Bao-nian Liu6Ke Ning7Jia-jia Liu8Ya-chao Wang9Jin-xia Mi10Xiaohui Wei11Shui-jin Shao12Guo-hong Cui13Rong Lu14Hai-dong Guo15Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Biochemistry, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaSchool of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Histoembryology, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Physiology, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaAcademy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaAcademy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaScience and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaThe MOE Key Laboratory for Standardization of Chinese Medicines and the SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, ChinaDepartment of Neurology, Shanghai No. 9 People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China; Corresponding author.School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Corresponding author.Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Department of Anatomy, School of Basic Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Corresponding author. Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.Notoginsenoside R1 (NGR1) is the main monomeric component extracted from the dried roots and rhizomes of Panax notoginseng, and exerts pharmacological action against myocardial infarction (MI). Owing to the differences in compound distribution, absorption, and metabolism in vivo, exploring a more effective drug delivery system with a high therapeutic targeting effect is crucial. In the early stages of MI, CD11b-expressing monocytes and neutrophils accumulate at infarct sites. Thus, we designed a mesoporous silica nanoparticle-conjugated CD11b antibody with loaded NGR1 (MSN-NGR1-CD11b antibody), which allowed NGR1 precise targeted delivery to the heart in a noninvasively manner. By increasing targeting to the injured myocardium, intravenous injection of MSN-NGR1-CD11b antibody nanoparticle in MI mice improved cardiac function and angiogenesis, reduced cell apoptosis, and regulate macrophage phenotype and inflammatory factors and chemokines. In order to further explore the mechanism of NGR1 protecting myocardium, cell oxidative stress model and oxygen-glucose deprivation (OGD) model were established. NGR1 protected H9C2 cells and primary cardiomyocytes against oxidative injury induced by H2O2 and OGD treatment. Further network pharmacology and molecular docking analyses suggested that the AKT, MAPK and Hippo signaling pathways were involved in the regulation of NGR1 in myocardial protection. Indeed, NGR1 could elevate the levels of p-Akt and p-ERK, and promote the nuclear translocation of YAP. Furthermore, LY294002 (AKT inhibitor), U0126 (ERK1/2 inhibitor) and Verteporfin (YAP inhibitor) administration in H9C2 cells indicated the involvement of AKT, MAPK and Hippo signaling pathways in NGR1 effects. Meanwhile, MSN-NGR1-CD11b antibody nanoparticles enhanced the activation of AKT and MAPK signaling pathways and the nuclear translocation of YAP at the infarcted site. Our research demonstrated that MSN-NGR1-CD11b antibody nanoparticle injection after MI enhanced the targeting of NGR1 to the infarcted myocardium and improved cardiac function. More importantly, our pioneering research provides a new strategy for targeting drug delivery systems to the ischemic niche.http://www.sciencedirect.com/science/article/pii/S2213231722001562Myocardial infarctionNotoginsenoside R1Mesoporous silica nanoparticlesPI3K/AKT signaling pathwayMAPK signaling pathwayHippo signaling pathway |
| spellingShingle | Han Li Jing Zhu Yan-wu Xu Fang-fang Mou Xiao-li Shan Qiang-li Wang Bao-nian Liu Ke Ning Jia-jia Liu Ya-chao Wang Jin-xia Mi Xiaohui Wei Shui-jin Shao Guo-hong Cui Rong Lu Hai-dong Guo Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction Redox Biology Myocardial infarction Notoginsenoside R1 Mesoporous silica nanoparticles PI3K/AKT signaling pathway MAPK signaling pathway Hippo signaling pathway |
| title | Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction |
| title_full | Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction |
| title_fullStr | Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction |
| title_full_unstemmed | Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction |
| title_short | Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction |
| title_sort | notoginsenoside r1 loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction |
| topic | Myocardial infarction Notoginsenoside R1 Mesoporous silica nanoparticles PI3K/AKT signaling pathway MAPK signaling pathway Hippo signaling pathway |
| url | http://www.sciencedirect.com/science/article/pii/S2213231722001562 |
| work_keys_str_mv | AT hanli notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT jingzhu notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT yanwuxu notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT fangfangmou notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT xiaolishan notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT qiangliwang notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT baonianliu notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT kening notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT jiajialiu notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT yachaowang notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT jinxiami notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT xiaohuiwei notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT shuijinshao notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT guohongcui notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT ronglu notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction AT haidongguo notoginsenosider1loadedmesoporoussilicananoparticlestargetingthesiteofinjurythroughinflammatorycellsimprovesheartrepairaftermyocardialinfarction |